FRATES JAMES M

Average Profitability
11.01%
Insider Buys Quantity
3
Insider Buys Sum
$291,102.62
Insider Sells Quantity
83
Insider Sells Sum
$57.04M

Insider Activity of FRATES JAMES M

According to the SEC Form 4 filings, FRATES JAMES M, being in a position of

  1. Chief Financial Officer at Amylyx Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 40000 shares for $101,368, and sold 4508 shares for $77,908,
    over all time since 2023-01-06, has bought 40000 shares for $101,368, and sold 72166 shares for $2.09M.

The largest purchase of all time was on 2024-09-12 and amounted to 40000 shares of Amylyx Pharmaceuticals, Inc. for $101,368.

The largest sale of all time was on 2017-03-07 and amounted to 50000 shares of Alkermes plc for $2.95M.

Biography of FRATES JAMES M

No biography is available at this moment.

2024-09-12PurchaseAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
40,000
0.0267%
$2.53$101,368+87.15%
2024-03-05SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
1,792
0.0088%
$18.73$33,560-87.85%
2024-01-09SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
2,716
0.0117%
$16.33$44,347-83.29%
2023-05-16SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
32,500
0.2305%
$26.94$875,451-37.99%
2023-03-16SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
32,500
0.2729%
$31.89$1.04M-38.87%
2023-01-06SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Financial Officer
2,658
0.0254%
$36.30$96,481-39.04%
2021-06-16PurchaseSage Therapeutics, Inc.
SAGE
director
1,810
0.0031%
$55.10$99,735-24.87%
2019-08-15SaleSage Therapeutics, Inc.
SAGE
director
8,000
0.0154%
$160.58$1.28M-58.68%
2019-05-06SaleSage Therapeutics, Inc.
SAGE
director
8,000
0.0148%
$162.22$1.3M-17.11%
2019-01-23SaleSage Therapeutics, Inc.
SAGE
director
15,000
0.017%
$71.86$1.08M+21.46%
2018-06-12SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
33,684
0.0218%
$50.00$1.68M-29.67%
2018-05-08SaleSage Therapeutics, Inc.
SAGE
director
14,000
0.0156%
$81.46$1.14M-4.07%
2017-11-29SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
41,864
0.0267%
$50.51$2.11M-12.24%
2017-11-08SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
41,864
0.017%
$29.94$1.25M-4.6%
2017-03-07SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
50,000
0.0329%
$59.08$2.95M-4.12%
2016-12-14SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
50,000
0.0328%
$54.73$2.74M+0.97%
2016-12-07SaleAlkermes plc
ALKS
SVP, Alks Inc; CFO ALKS
47,462
0.0317%
$56.28$2.67M+0.13%
2015-11-10SaleAlkermes plc
ALKS
SVP & CFO, Alkermes plc
20,000
0.008%
$44.14$882,895-38.74%
2015-10-13SaleAlkermes plc
ALKS
SVP & CFO, Alkermes plc
40,000
0.0277%
$59.78$2.39M-21.04%
2015-09-15SaleAlkermes plc
ALKS
SVP & CFO, Alkermes plc
40,000
0.0266%
$71.10$2.84M-35.44%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.